Medicine and Health

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

Y. Du, R. Shi, et al.

Discover the groundbreaking research on h11B11, an ACE2-blocking monoclonal antibody that demonstrates exceptional efficacy in inhibiting SARS-CoV and SARS-CoV-2. Conducted by an expert team including Yanyun Du and Rui Shi, this study unveils promising therapeutic and preventive strategies against viral replication with minimal toxicity.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery

X. Zhang, H. Zhang, et al.

Medicine and Health

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection

L. M. Coria, J. M. Rodriguez, et al.

Medicine and Health

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

C. Kim, D. Ryu, et al.

Medicine and Health

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination

X. Chi, Y. Guo, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny